1-Year Outcomes with COMBO Stents in Small-Vessel Coronary Disease: Subgroup Analysis From the COMBO Collaboration-Reference-Cited by-同舟云学术

1-Year Outcomes with COMBO Stents in Small-Vessel Coronary Disease: Subgroup Analysis From the COMBO Collaboration

Published:2020-12 Issue:12 Volume:21 Page:1542-1547
ISSN:1553-8389
Container-title:Cardiovascular Revascularization Medicine
language:en
Short-container-title:Cardiovascular Revascularization Medicine

Author:

Chandrasekhar Jaya,Zeebregts Doreen,Kalkman Deborah N.,Sartori Samantha,Roumeliotis Anastasios,Aquino Melissa B.,de Wilde Puk,de Winter Vera C.,Baber Usman,Woudstra Pier,Beijk Marcel A.,Hájek Petr,Atzev Borislav,Hudec Martin,Ong Tiong Kiam,Mates Martin,Borisov Borislav,Warda Hazem M.,den Heijer Peter,Wojcik Jaroslaw,Iniguez Andres,Lee Michael,Tijssen Jan G.,Koch Karel T.,Dangas George D.,Colombo Antonio,Mehran Roxana,de Winter Robbert J.

Funder

OrbusNeich Medical BV

OrbusNeich Medical

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference28 articles.

1. Drug-eluting or bare-metal stents for coronary artery disease;Bonaa;N Engl J Med,2016

2. Relationship between stent diameter, platelet reactivity, and thrombotic events after percutaneous coronary artery revascularization;Redfors;Am J Cardiol,2019

3. Effect of stent diameter in women undergoing percutaneous coronary intervention with early- and new-generation drug-eluting stents: from the WIN-DES collaboration;Camaj;Int J Cardiol,2019

4. Impact of stent diameter on outcomes following percutaneous coronary intervention with second-generation drug-eluting stents: results from a large single-center registry;Plitt;Catheter Cardiovasc Interv,2020

5. Drug-coated balloons for small coronary vessel interventions: a literature review;Nestelberger;Interv Cardiol,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endothelial progenitor cells and coronary artery disease: Current concepts and future research directions;World Journal of Clinical Cases;2021-10-26

2. The Bioengineered Combo Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Coronary Stent in Patients with Chronic Total Occlusion Evaluated by Clinical Outcome and Optical Coherence Tomography Imaging Analysis;Journal of Clinical Medicine;2020-12-28

3. Not a Small Problem: Is the COMBO Stent a Solution to the Challenges of DES in Small Vessels?;Cardiovascular Revascularization Medicine;2020-12